table of content
Table of Contents
Post-pandemic Era-Global Next-Generation Breast Cancer Diagnostic and Screening Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Real-Time PCR (q-PCR) -Product Introduction and Major Company
1.1.2 Immunohistochemistry (IHC) -Product Introduction and Major Company
1.1.3 Next-Generation Sequencing (NGS) -Product Introduction and Major Company
1.1.4 Fluorescent In-Situ Hybridization (FISH) -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Next-Generation Breast Cancer Diagnostic and Screening Market Assessment by Type
3.1 Global Next-Generation Breast Cancer Diagnostic and Screening Sales by Type (2018-2028)
3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Type (2018-2028)
3.3 North America Next-Generation Breast Cancer Diagnostic and Screening Sales and Revenue by Type (2018-2028)
3.4 Asia Next-Generation Breast Cancer Diagnostic and Screening Sales and Revenue by Type (2018-2028)
3.5 Europe Next-Generation Breast Cancer Diagnostic and Screening Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Sales and Revenue by Type (2018-2028)
3.7 South America Next-Generation Breast Cancer Diagnostic and Screening Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Next-Generation Breast Cancer Diagnostic and Screening Market Assessment by Application
4.1 Global Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Next-Generation Breast Cancer Diagnostic and Screening Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
6.3 India Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
7.3 France Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue and Growth Rate (2018-2028)
10 Global Next-Generation Breast Cancer Diagnostic and Screening Average Price Trend
10.1 Market Price for Each Type of Next-Generation Breast Cancer Diagnostic and Screening in North America (2018-2028)
10.2 Market Price for Each Type of Next-Generation Breast Cancer Diagnostic and Screening in Asia (2018-2028)
10.3 Market Price for Each Type of Next-Generation Breast Cancer Diagnostic and Screening in Europe (2018-2028)
10.4 Market Price for Each Type of Next-Generation Breast Cancer Diagnostic and Screening in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Next-Generation Breast Cancer Diagnostic and Screening in South America (2018-2028)
11 Value Chain
11.1 Next-Generation Breast Cancer Diagnostic and Screening Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Next-Generation Breast Cancer Diagnostic and Screening Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Next-Generation Breast Cancer Diagnostic and Screening Market, Competitive Analysis
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Profiles and Company News
12.1.2 Abbott Laboratories Product Introduction
12.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Agendia
12.2.1 Agendia Company Profiles and Company News
12.2.2 Agendia Product Introduction
12.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Profiles and Company News
12.3.2 Agilent Technologies Product Introduction
12.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Ambry Genetics
12.4.1 Ambry Genetics Company Profiles and Company News
12.4.2 Ambry Genetics Product Introduction
12.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 EXACT Sciences Corporation
12.5.1 Biocept Company Profiles and Company News
12.5.2 Biocept Product Introduction
12.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Biotheranostics
12.6.1 Biotheranostics Company Profiles and Company News
12.6.2 Biotheranostics Product Introduction
12.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Centogene
12.7.1 Centogene Company Profiles and Company News
12.7.2 Centogene Product Introduction
12.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Danaher Corporation
12.8.1 Danaher Corporation Company Profiles and Company News
12.8.2 Danaher Corporation Product Introduction
12.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 EXACT Sciences Corporation
12.9.1 EXACT Sciences Corporation Company Profiles and Company News
12.9.2 EXACT Sciences Corporation Product Introduction
12.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Roche Holding AG
12.10.1 Roche Holding AG Company Profiles and Company News
12.10.2 Roche Holding AG Product Introduction
12.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
12.11 Fulgent Genetics
12.12 Illumina
12.13 Invitae
12.14 Lucence Diagnostics Pte Ltd
12.15 Myriad Genetics
13 Global Next-Generation Breast Cancer Diagnostic and Screening Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Next-Generation Breast Cancer Diagnostic and Screening Market
13.2 Concentration Ratio (CR5) of Global Next-Generation Breast Cancer Diagnostic and Screening Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Next-Generation Breast Cancer Diagnostic and Screening Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
